[
    [
        {
            "time": "",
            "original_text": "医药投资标|新版化药、生物制品注册分类出台；君实生物确定科创板发行价55.50元/股；长风药业半年内再获3.6亿元F轮融资",
            "features": {
                "keywords": [
                    "医药",
                    "化药",
                    "生物制品",
                    "注册分类",
                    "君实生物",
                    "科创板",
                    "发行价",
                    "长风药业",
                    "融资"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药投资标|新版化药、生物制品注册分类出台；君实生物确定科创板发行价55.50元/股；长风药业半年内再获3.6亿元F轮融资",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]